Real-world data shows kovaltry safely controls bleeds in hemophilia a
NCT ID NCT02941783
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 31 times
Summary
This study followed 230 people with hemophilia A who were already prescribed Kovaltry to see how safe it is and how well it controls bleeding in everyday medical practice. Researchers tracked side effects and how many bleeds occurred. The goal was to gather real-world information, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA A are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Many Locations
Multiple Locations, Japan
Conditions
Explore the condition pages connected to this study.